Brain Hemorrhage – Pipeline Review, H1 2012 (Related Reports)

Brain Hemorrhage – Pipeline Review, H1 2012


March 19, 2012
41 Pages - SKU: GMD3811069
License type:
Online Download      US $500.00
Global Site License      US $1,500.00
Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014 provides data on the Recurrent Glioblastoma Multiforme (GBM) clinical trial scenario. This  |  read more...
$2,500.00
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018
4/14/2014 | published by: MarketsandMarkets
Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018 The global cell analysis market  |  read more...
$4,650.00
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
4/14/2014 | published by: GBI Research
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business intelligence provider GBI Research has released its latest research report,  |  read more...
$3,500.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Pipeline Review, H1 2014’, provides an overview of the Acute Respiratory Distress Syndrome’s therapeutic pipeline. This report provides comprehensive information  |  read more...
$2,000.00
Opium (Opioid) Addiction - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Opium (Opioid) Addiction - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Opium (Opioid) Addiction - Pipeline Review, H1 2014’, provides an overview of the Opium (Opioid) Addiction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Polycystic Kidney Disease - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polycystic Kidney Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polycystic Kidney Disease - Pipeline Review, H1 2014’, provides an overview of the Polycystic Kidney Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
African Trypanosomiasis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
African Trypanosomiasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H1 2014’, provides an overview of the African Trypanosomiasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for African  |  read more...
$2,000.00